$DGNMF News
Last published 1w ago
- 1w agoDGNMFDiagnaMed Holdings Corp. Announces Refiling of Its Annual and Interim Financial Statements and related MD&AGlobeNewswireToronto, Ontario, Nov. 04, 2026 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (CSE:DMED) (OTCQB:DGNMF) (the "Company") today announced that it has amended and refiled its annual and interim financial
- 1y agoDGNMFDiagnaMed Appoints John Karagiannidis as President & CEO; Fabio Chianelli Transitions to Director Role Strengthening Strategic Partnership with QIMC to Accelerate Natural Hydrogen Development in OntarioGlobeNewswireTORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (""DiagnaMed" or "DMED") (CSE:DMED) (OTCQB:DGNMF), a Canadian technology innovator specializing in advanced hydrogen extraction technologies,
- 1y agoDGNMFDiagnaMed Expands Clean Hydrogen Energy Extraction Capabilities to Demonstrate Proof of Concept of Proprietary TechnologyGlobeNewswireTORONTO, June 05, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a Canadian technology innovator specializing in advanced hydrogen extraction technologies, is
- 1y agoDGNMFQIMCFDiagnaMed Acquires Strategic Ontario Claims Adjacent to QIMC in Premier Temiscamingue Hydrogen DistrictGlobeNewswireTORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a Canadian technology innovator specializing in advanced hydrogen extraction technologies, is
- 1y agoDGNMFRVVTFRevive Therapeutics Announces Acquisition of Molecular Hydrogen ProgramGlobeNewswireTORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB:RVVTF) (CSE:RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of
- 1y agoDGNMFRVVTFRevive Therapeutics Announces LOI to Acquire DiagnaMed's Molecular Hydrogen ProgramGlobeNewswireTORONTO, March 03, 2025 (GLOBE NEWSWIRE) -- TORONTO, March 3, 2025 – Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB:RVVTF) (CSE:RVV) (FRANKFURT:31R), a specialty life sciences company focused on the
- 1y agoDGNMFDiagnaMed Advances Hydrogen Energy Technology InnovationGlobeNewswireTORONTO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed", "DMED", or the "Company") (CSE:DMED) (OTCQB:DGNMF), a leading provider of cutting-edge technology solutions for the hydrogen and life
- 1y agoDGNMFQIMCFDiagnaMed and TerraVent Announce Strategic Collaboration for Next-Generation Clean Hydrogen ProductionGlobeNewswireTORONTO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a leading provider of innovative technology solutions for the cleantech and life sciences
- 1y agoDGNMFDiagnaMed Announces Resignation of Director and Grant of Stock OptionsGlobeNewswireTORONTO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF) announces that Elyssia Patterson has resigned from the board. The Company also announces that
- 1y agoDGNMFQIMCFDiagnaMed and QIMC to Advance Hydrogen Production Technology at the Ville Marie Clean Natural Renewable Hydrogen ProjectGlobeNewswireTORONTO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a leading innovator in hydrogen production technologies and artificial intelligence (AI)
- 1y agoDGNMFDiagnaMed Partners with Texas Tech University to Pioneer Hydrogen InnovationGlobeNewswireTORONTO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a leading innovator in hydrogen-producing technologies and artificial intelligence (AI)
- 1y agoDGNMFDiagnaMed and EIREX Collaborate to Develop and Commercialize Novel Modular Technology Producing Hydrogen from WaterGlobeNewswireTORONTO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a life sciences company focused on molecular hydrogen and AI diagnostics, is pleased to
- 1y agoDGNMFDiagnaMed Announces Stock Option Grants and Shares for Debt SettlementGlobeNewswireTORONTO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a life sciences company focused on molecular hydrogen and AI diagnostics, announces that it
- 2y agoDGNMFDiagnaMed Files U.S. Patent Application for Novel Methods of Producing Molecular HydrogenGlobeNewswireAdvancing molecular hydrogen for neurological and mental health disorders Expects its molecular hydrogen product to be ready for use in December 2024 TORONTO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings
- 2y agoDGNMFDiagnaMed Advancing the Medical Potential of HydrogenGlobeNewswireTORONTO, Oct. 30, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a life sciences company focused on brain health, announces its strategic initiative in
- 2y agoDGNMFDiagnaMed Expands with Drug and Clinical Research AI PlatformGlobeNewswireLeveraging proprietary EEG data from previous and future research studies with BRAIN AGE® Brain Health AI Accelerating clinical trial development and discovering potential novel treatments for neurological,
- 2y agoDGNMFDiagnaMed Offering its Brain Health AI Platform for Investigating Weight Loss Drugs, such as Semaglutide (GLP-1), on Brain FunctionGlobeNewswireTORONTO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a healthcare technology company focused on brain health using AI, is offering its novel BRAIN
- 2y agoDGNMFDiagnaMed Cancels Previously Announced Private PlacementGlobeNewswireTORONTO, July 03, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a healthcare technology company focused on brain health using AI, announces it has cancelled
- 2y agoDGNMFDiagnaMed Announces LIFE Offering of up to $650,000GlobeNewswireTORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a healthcare technology company focused on brain health using AI, is pleased to announce that
- 2y agoDGNMFDiagnaMed's BRAIN AGE® Brain Health AI Platform Targeting Multi-Billion Digital Brain Health MarketGlobeNewswireTORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a healthcare technology company focused on brain health using AI, is commercializing its novel
- 2y agoDGNMFDiagnaMed's BRAIN AGE® Brain Health AI Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed PaperGlobeNewswireTORONTO, April 25, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a healthcare technology company focused on brain health using AI, today announced a clinical
- 2y agoDGNMFDiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AIGlobeNewswireClinics can apply at BrainAge.ca TORONTO, April 23, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a healthcare technology company focused on brain health
- 2y agoDGNMFDiagnaMed Adds New Launch Site of CERVAI™ Brain Health AIGlobeNewswireTORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), an artificial intelligence digital healthcare company, today announced it has added Drexel
- 2y agoDGNMFDiagnaMed Announces BRAIN AGE® Trademark Registration Approved by CIPOGlobeNewswireTORONTO, March 20, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), an artificial intelligence digital healthcare company, announced its application for
- 2y agoDGNMFDiagnaMed Strengthening Intellectual Property Support for CERVAI™ Brain Health AI SolutionGlobeNewswireTORONTO, March 14, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), an artificial intelligence digital healthcare company, is pleased to announce it has
- 2y agoDGNMFDiagnaMed Accelerates Commercialization Initiatives of CERVAI™ Brain Health AI SolutionGlobeNewswireTORONTO, March 11, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), an artificial intelligence digital healthcare company, is pleased to announce that it has
- 2y agoDGNMFDiagnaMed Announces Test Launch of CERVAI™ Brain Health in University Brain Health CenterGlobeNewswireTORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a digital health artificial intelligence company focused on brain health, today announced a
- 2y agoDGNMFDiagnaMed Announces Pilot Launch of CERVAI™ Brain Health AI SolutionGlobeNewswireTORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a digital health artificial intelligence company focused on brain health, today announced the
- 2y agoDGNMFDiagnaMed Accelerates Commercialization of CERVAI™ Brain Health AI Platform with Acceptance into the SOPHIE ProgramGlobeNewswireTORONTO, Nov. 15, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a generative artificial intelligence healthcare company, is pleased to announce it has been
- 3y agoDGNMFDiagnaMed Launches New Healthcare Provider Network Program for CERVAI™ Brain Health AI Platform in Canada and the USAGlobeNewswireTORONTO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a generative artificial intelligence healthcare company, announced today the launch of
- 3y agoDGNMFDiagnaMed Provides Update for its Brain Health AI Platform, CERVAI™GlobeNewswireTORONTO, Sept. 13, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a generative artificial intelligence healthcare company, provides a development and
- 3y agoDGNMFDiagnaMed Provides Update on CERVAI™, a Brain Health AI Platform Leveraging Generative AIGlobeNewswireTORONTO, June 20, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a generative artificial intelligence ("AI") healthcare company, is pleased to announce an
- 3y agoDGNMFDiagnaMed Launches a Generative Artificial Intelligence Medical Chatbot, Dr. GenAIGlobeNewswireTORONTO, June 15, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a generative AI healthcare company, is pleased to announce the launch of Dr. GenAI
- 3y agoDGNMFDiagnaMed Launches PalGPT.ai, a Generative AI Brain Health SolutionGlobeNewswireTORONTO, May 25, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a generative AI healthcare solutions company, is pleased to announce the launch of PalGPT.ai
- 3y agoDGNMFDiagnaMed Announces DTC Eligibility of Its Common Shares in the United StatesGlobeNewswireTORONTO, May 17, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a generative AI healthcare solutions company, is pleased to announce that its OTCQB-listed
- 3y agoDGNMFDiagnaMed Launches "Health GenAI", a New Division for Generative AI Healthcare SolutionsGlobeNewswireTORONTO, May 10, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a generative AI healthcare solutions company, is pleased to announce the launch of Health
- 3y agoDGNMFDiagnaMed Launches FormGPT.io, a Generative AI Healthcare SolutionGlobeNewswireTORONTO, May 03, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a generative AI healthcare solutions company, is pleased to announce the launch of FormGPT.io,
- 3y agoDGNMFDiagnaMed Announces Listing on OTCQB in the United StatesGlobeNewswireTORONTO, April 11, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a digital health AI company, is pleased to announce that effective April 11, 2023, the